Search Results

You are looking at 1 - 10 of 68 items for :

  • transdermal drug delivery x
Clear All
Open access

Othman A. Al Hanbali, Haji Muhammad Shoaib Khan, Muhammad Sarfraz, Mosab Arafat, Shakeel Ijaz and Abdul Hameed

REFERENCES 1. L. Zhang and S. Mao, Application of quality by design in the current drug development, As. J. Pharm. Sci . 12 (2017) 1–8; https://doi.org/10.1016/j.ajps.2016.07.006 2. M. R. Prausnitz and R. Langer, Transdermal drug delivery, Nat. Biotechnol . 26 (2008) 1261–1268; https://doi.org/10.1038/nbt.1504 3. M. J. Tsai, I. J. Lu, Y. S. Fu, Y.P. Fang, Y. B. Huang and P. C. Wu, Nanocarriers enhance the transdermal bioavailability of resveratrol: In-vitro and in-vivo study, Colloids Surf. B Biointerfaces 148 (2016) 650–656; https

Open access

A. Walicka and B. Iwanowska-Chomiak

References [1] Walicka A. (2017): Rheology of Fluids in Mechanical Engineering . – Zielona Góra: University Press. [2] Mandelbrot B.B. (1967): How long is the coast of Britain? Statistical self-similarity and fractional dimension . – Science, vol.155, pp.636-638. [3] Mandelbrot B.B. (1982): The Fractal Geometry of Nature . – New York: W.H. Freeman. [4] Kalia Y.N. and Guy R.H. (2001): Modeling transdermal drug release . – Adv. Drug Delivery Rev., vol.48, pp.159-172. [5] Carreras N., Alonso C., Marti M. and Lis M.J. (2015): Mass

Open access

A. Walicka, J. Falicki and B. Iwanowska-Chomiak

References [1] Lukas L. (1988): The epidermal permeability barrier . – Anat. Embryol, No.178, pp.1-13. [2] Peter M.E. (1988): Structure and function of stratum corneum permeability barrier . – Drug Develop. Res., vol.13, No.1, pp.97-105. [3] Kalia Y.N. and Guy R.H. (2001): Modeling transdermal drug release . – Adv. Drug Delivery Rev., vol.48, pp.159-172. [4] Carreras N., Alonso C., Marti M. and Lis M.J. (2015): Mass transport model through the skin by microencapsulation system . – J. Microencapsulation, vol.32, No.4, pp.358

Open access

Priya Prasad Verma and Ashok Chandak

References J. W. Wiechers, The barrier functions of the skin in relation to percutaneous absorption of drugs, Pharm. Weekbl. 11 (1989) 185--198. D. C. Monkhouse and A. S. Huq, Transdermal drug delivery - problems and promises, Drug Dev. Ind. Pharm. 14 (1988) 183--203. M. B. Brown, G. P. Martin, S. A. Jones and F. K. Akomeah, Dermal and transdermal drug delivery systems: Current and future prospects, Drug Del. 13 (2006) 175--187; DOI: 10

Open access

Ashu Mittal, Udai Sara and Asgar Ali

and M. Aqil, The effect of penetration enhancers on permeation kinetics of nitrendipine in two different skin models, Biol. Pharm. Bull. 31 (2008) 1766-1772; DOI: 10.1248/bpb.31.1766. M. Aqil, A. Ali, Y. Sultana and P. Nayyar, Matrix type transdermal drug delivery systems of metoprolol tartrate: skin toxicity and in vivo characterization, Ethiop. Pharm. J. 22 (2004) 53-60. P. Arora and M. Biswajit, Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containg

Open access

Paula Antonoaea, Nicoleta Todoran, Emőke Rédai, Adriana Ciurba, Cătălina Bogdan, Mirela Moldovan and Daniela Lucia Muntean

References 1. Singh I, Morris AP - Performance of transdermal therapeutic systems: Effects of biological factors. Int J Pharm Investig. 2011;1(1):4-9. 2. Popovici I, Lupuleasa D - Tehnologie farmaceutică vol.2, București, Polirom, 2008, 841-888. 3. Patel D, Chaudhary SA, Parmar B, Bhura N - Transdermal drug delivery system: a review. J Pharm Innov. 2012;4:78-87. 4. Yadav V - Transdermal drug delivery system: review. Int J Pharm Sci Res. 2012;3(2):376-382. 5. Ting L, Changshun R

Open access

A. Walicka and B. Iwanowska-Chomiak

References [1] Kalia Y.N. and Guy R.H. (2001): Modeling transdermal drug release . – Adv. Drug Delivery Rev., vol.48, pp.159-172. [2] Carreras N., Alonso C., Marti M. and Lis M.J. (2015): Mass transport model through the skin by microencapsulation system . – J. Microencapsulation, vol.32, No.4, pp.358-363. [3] Cal K. (2009): Across skin barrier; known methods, new performances . – In: Frontiers in Drug Design and Discovery, vol.4 (Caldwell G.W., ur-Rahman A., Yan Z., Choudhary M.J., Eds), pp.162-188. [4] Cal K. and Stefanowska J. (2010

Open access

Bazigha Rasool, Uday Aziz, Omar Sarheed and Alaa Rasool

, Evaluation of skin damage of cyclic monoterpenes, percutaneous absorption enhancers by using cultured human skin cells, Biol. Pharm. Bull.   16 (1993) 912-916. K. K. Peh and C. F. Wong, Polymeric film as vehicle for buccal delivery: Swelling, mechanical and bioadhesive properties, J. Pharm. Pharm. Sci.   2 (1999) 53-61. C. Amnuaikit, I. Ikeuchi, K. Ogawara, K. Higaki, Kazutaka and T. Kimura, Skin permeation of propranolol HCl from polymeric film containing terpene enhancers for transdermal use, Int. J. Pharm.   289

Open access

Paula Antonoaea, Anca Gabriela Cârje, Adriana Ciurba, Nicoleta Todoran, Alexandru Robert Vlad and Daniela Lucia Muntean

References 1. Singh VK, Pokhariyal T, Tiwari AK - Transdermal drug delivery system for non-steroidial anti inflammatory drugs: a review. Indo Am J Pharm Res. 2013;3(4):3588-3604. 2. Rastogi V, Yadav P - Transdermal drug delivery system: an overview. Asian J Pharm. 2012;6(3):161-170. 3. Premjeet S, Bilandi A, Sahil K, Akanksha M - Transdermal drug delivery system (patches), applications in present scenario. IJRPC. 2011;1(4):1139-1151. 4. Cristea AN - Tratat de farmacologie, Bucureşti, Ed. Medicală, 2009, 617-633. 5. Gopal V, Rose C

Open access

M. Žabka, M. Hukeľová, M. Čuchorová and L. Starýchová

ibuprofen for topical delivery. Int. J. Pharm. 2006;315:52-58. Maghraby GM. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: Effect of phase transition. Colloids Surf B. 2010;75:595-600. Open Data Drug & Drug Target Database ( http://www.drugbank.ca/drugs/DB00328 Sakaeda T, Hirano K. Effect of composition on biological fate of oil particles after intravenous injection of o/w lipid emulsions. J Drug Target. 1998;6:273-284. Slovak